Partial least squares Discriminant analysis on MS studies

This analysis uses the "muma" package of the R statistics environment (Reference)

Click on links below to perform analysis.

PLSDA	Study ID	Scaling	Study Title	MS Analysis Type
	ST000916	Auto Pareto Vast Median Range None	Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 2:Plasma	Core G Fatty acids/Eicosanoids
	ST000916	Auto Pareto Vast Median Range None	Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 2:Plasma	Core J Sterols
	ST000916	Auto Pareto Vast Median Range None	Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 2:Plasma	Core K Prenols/Cardiolipins
	ST000916	Auto Pareto Vast Median Range None	Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 2:Plasma	Core E Neutral Lipids
	ST000916	Auto Pareto Vast Median Range None	Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 2:Plasma	Core I Sphingolipids
	ST000916	Auto Pareto Vast Median Range None	Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 2:Plasma	Core H Phospholipids